IWM
PDLI

IHT Wealth Management’s PDL BioPharma, Inc. PDLI Stock Holding History

IHT Wealth Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-425
Closed -$333 – 1591
2017
Q2 		$333 Hold
425
– – 0.16% 155
2017
Q1 		$1K Buy
+425
New +$940 ﹤0.01% 1262

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IHT Wealth Management's PDLI Position: Q3 2017 in Review

IHT Wealth Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2017, closing a stake of 425 shares — an estimated $333 sold.

IHT Wealth Management first reported a position in PDLI in Q1 2017 and held it in 2 quarters. The position peaked at $1K in Q1 2017. 186 funds tracked by Wall St. Rank hold PDLI as of Q3 2017.

  • IHT Wealth Management reported no remaining PDL BioPharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • IHT Wealth Management sold 425 PDL BioPharma, Inc. shares in Q3 2017, an estimated $333.
  • IHT Wealth Management first reported a position in PDL BioPharma, Inc. in Q1 2017 and held it in 2 quarters.
  • IHT Wealth Management's PDL BioPharma, Inc. position peaked at $1K in Q1 2017.
  • 186 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2017.

Based on IHT Wealth Management's 13F filing for Q3 2017, filed 14 Nov 2017.